Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Paramagnetic Mn8Fe4-co-Polystyrene Nanobeads as a Potential T1-T2 Multimodal Magnetic Resonance Imaging Contrast Agent with In Vivo Studies.
Dahanayake V, Lyons T, Kerwin B, Rodriguez O, Albanese C, Parasido E, Lee Y, Keuren EV, Li L, Maxey E, Paunesku T, Woloschak G, Stoll SL. Dahanayake V, et al. Among authors: parasido e. ACS Appl Mater Interfaces. 2021 Aug 25;13(33):39042-39054. doi: 10.1021/acsami.1c09232. Epub 2021 Aug 10. ACS Appl Mater Interfaces. 2021. PMID: 34375073 Free PMC article.
Paramagnetic Clusters of Mn3(O2CCH3)6(Bpy)2 in Polyacrylamide Nanobeads as a New Design Approach to a T1- T2 Multimodal Magnetic Resonance Imaging Contrast Agent.
Dahanayake V, Pornrungroj C, Pablico-Lansigan M, Hickling WJ, Lyons T, Lah D, Lee Y, Parasido E, Bertke JA, Albanese C, Rodriguez O, Van Keuren E, Stoll SL. Dahanayake V, et al. Among authors: parasido e. ACS Appl Mater Interfaces. 2019 May 22;11(20):18153-18164. doi: 10.1021/acsami.9b03216. Epub 2019 May 7. ACS Appl Mater Interfaces. 2019. PMID: 30964631 Free PMC article.
Predicting new drug indications for prostate cancer: The integration of an in silico proteochemometric network pharmacology platform with patient-derived primary prostate cells.
Naeem A, Dakshanamurthy S, Walthieu H, Parasido E, Avantaggiati M, Tricoli L, Kumar D, Lee RJ, Feldman A, Noon MS, Byers S, Rodriguez O, Albanese C. Naeem A, et al. Among authors: parasido e. Prostate. 2020 Oct;80(14):1233-1243. doi: 10.1002/pros.24050. Epub 2020 Aug 6. Prostate. 2020. PMID: 32761925 Free PMC article.
A novel chemo-phenotypic method identifies mixtures of salpn, vitamin D3, and pesticides involved in the development of colorectal and pancreatic cancer.
Issa NT, Wathieu H, Glasgow E, Peran I, Parasido E, Li T, Simbulan-Rosenthal CM, Rosenthal D, Medvedev AV, Makarov SS, Albanese C, Byers SW, Dakshanamurthy S. Issa NT, et al. Among authors: parasido e. Ecotoxicol Environ Saf. 2022 Mar 15;233:113330. doi: 10.1016/j.ecoenv.2022.113330. Epub 2022 Feb 19. Ecotoxicol Environ Saf. 2022. PMID: 35189517 Free PMC article.
The mitochondrial citrate carrier, SLC25A1, drives stemness and therapy resistance in non-small cell lung cancer.
Fernandez HR, Gadre SM, Tan M, Graham GT, Mosaoa R, Ongkeko MS, Kim KA, Riggins RB, Parasido E, Petrini I, Pacini S, Cheema A, Varghese R, Ressom HW, Zhang Y, Albanese C, Üren A, Paige M, Giaccone G, Avantaggiati ML. Fernandez HR, et al. Among authors: parasido e. Cell Death Differ. 2018 Jul;25(7):1239-1258. doi: 10.1038/s41418-018-0101-z. Epub 2018 Apr 12. Cell Death Differ. 2018. PMID: 29651165 Free PMC article.
The induction of the p53 tumor suppressor protein bridges the apoptotic and autophagic signaling pathways to regulate cell death in prostate cancer cells.
Ringer L, Sirajuddin P, Tricoli L, Waye S, Choudhry MU, Parasido E, Sivakumar A, Heckler M, Naeem A, Abdelgawad I, Liu X, Feldman AS, Lee RJ, Wu CL, Yenugonda V, Kallakury B, Dritschilo A, Lynch J, Schlegel R, Rodriguez O, Pestell RG, Avantaggiati ML, Albanese C. Ringer L, et al. Among authors: parasido e. Oncotarget. 2014 Nov 15;5(21):10678-91. doi: 10.18632/oncotarget.2528. Oncotarget. 2014. PMID: 25296977 Free PMC article.
Regulation of Chemosensitivity in Human Medulloblastoma Cells by p53 and the PI3 Kinase Signaling Pathway.
Naeem A, Harish V, Coste S, Parasido EM, Choudhry MU, Kromer LF, Ihemelandu C, Petricoin EF, Pierobon M, Noon MS, Yenugonda VM, Avantaggiati M, Kupfer GM, Fricke S, Rodriguez O, Albanese C. Naeem A, et al. Among authors: parasido em. Mol Cancer Res. 2022 Jan;20(1):114-126. doi: 10.1158/1541-7786.MCR-21-0277. Epub 2021 Oct 11. Mol Cancer Res. 2022. PMID: 34635507 Free PMC article.
17 results